Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,470 GBX | -0.18% | +0.47% | +7.67% |
11:37am | BRITISH AMERICAN TOBACCO : Gets a Neutral rating from UBS | ZD |
May. 01 | British American Tobacco makes GBP173 million in buybacks | AN |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 3.24 times its current sales, is high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.91% | 69.73B | B- | ||
+6.11% | 155B | B- | ||
+25.08% | 6.33B | B- | ||
+97.20% | 2.6B | - | C+ | |
-4.61% | 1.8B | - | ||
-1.15% | 1.76B | - | D+ | |
-19.68% | 1.33B | - | B+ | |
0.00% | 656M | - | - | |
+28.95% | 598M | C+ | ||
-14.43% | 461M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BATS Stock
- Ratings British American Tobacco p.l.c.